NCT05080699
Evaluating Benefit of Peptide Based Diet in Obese HEN Patients
Enrolling by Invitation
NAAges 18+InterventionalTreatmentMayo ClinicInvestigator-initiated
~12 participants
Updated 2026-01-26 on ClinicalTrials.gov
What's tested:Peptamen Intense VHP, Nestlé Health Science, Switzerland
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in body weight
Measured over Baseline, 3 months
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Manpreet Mundi, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Home Enteral Nutrition (HEN) patient receiving at least 90% of energy needs from enteral nutrition.
BMI \> 30.
History of stroke.
Weight stable over the past month.
Exclusion
Diagnosis of cancer undergoing active treatment (chemotherapy, radiation, immunotherapy).
Life expectancy of less than 6 months.
Stage IV or higher kidney disease (GFR \< 30).
What this trial measures
- Change in body weightBaseline, 3 months
Change in body weight, measured in kg